These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 36533357)

  • 1. [Ruxolitinib as an effective treatment for panniculitis associated hemophagocytic syndrome: A report of 2 cases and literature review].
    Li GM; Jin YB; Gan YZ; Chen C; Jia Y; Li C
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1208-1213. PubMed ID: 36533357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic syndrome successfully treated with cyclosporin A.
    Al Zolibani AA; Al Robaee AA; Qureshi MG; Al Nosian H
    Skinmed; 2006; 5(4):195-7. PubMed ID: 16855414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ruxolitinib is an alternative to etoposide for patient with hemophagocytic lymphohistiocytosis complicated by acute renal injury: A case report.
    Yan WL; Yang SL; Zhao FY; Xu XJ
    J Oncol Pharm Pract; 2022 Jan; 28(1):222-227. PubMed ID: 34074166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of hemophagocytic syndrome in a patient with T cell lymphoma, EBV infection, and bone marrow necrosis: A case report.
    Xu L; Liu X; Wang Y; Wang Y; Chu X; Chen L
    Medicine (Baltimore); 2022 Mar; 101(9):e28943. PubMed ID: 35244052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic active Epstein-Barr virus-associated secondary hemophagocytic lymphohistiocytosis in pregnancy: a case report.
    Takahashi M; Makino S; Iizuka H; Noguchi M; Yoshida K
    BMC Pregnancy Childbirth; 2021 Oct; 21(1):681. PubMed ID: 34620104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ruxolitinib for secondary hemophagocytic lymphohistiocytosis: First case report.
    Sin JH; Zangardi ML
    Hematol Oncol Stem Cell Ther; 2019 Sep; 12(3):166-170. PubMed ID: 28834694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ruxolitinib for the treatment of lymphoma-associated hemophagocytic lymphohistiocytosis: A cautionary tale.
    Trantham T; Auten J; Muluneh B; Van Deventer H
    J Oncol Pharm Pract; 2020 Jun; 26(4):1005-1008. PubMed ID: 31575356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case Report: Baricitinib as an Alternative in the Maintenance Therapy for Macrophage Activation Syndrome Secondary to Nodular Panniculitis.
    Yi G; Huang Z; Huang Z; Wang Y; Deng W; Zheng S; Li T
    Front Immunol; 2022; 13():914265. PubMed ID: 35874753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic active Epstein-Barr virus infection associated with hemophagocytic syndrome and extra-nodal natural killer/T-cell lymphoma in an 18-year-old girl: A case report.
    Xing Y; Yang J; Lian G; Chen S; Chen L; Li F
    Medicine (Baltimore); 2017 May; 96(19):e6845. PubMed ID: 28489771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature.
    Hu S; Bansal P; Lynch D; Rojas Hernandez CM; Dayao Z
    J Med Case Rep; 2016 Dec; 10(1):365. PubMed ID: 27998299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Eperythrozoonosis complicated with hemophagocytic syndrome: report of four cases and review of literature].
    Li JG; Zhang D; Zhou ZX; Li SN; Kang M; Lai JM
    Zhonghua Er Ke Za Zhi; 2018 Apr; 56(4):303-307. PubMed ID: 29614573
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemophagocytic Lymphohistiocytosis Associated with Disseminated Nontuberculous Mycobacterial Infection in a Patient with Mesenteric Panniculitis.
    Fujita Y; Matsumoto H; Asano T; Sato S; Yashiro-Furuya M; Matsuoka N; Temmoku J; Nakatani-Enomoto S; Kimura S; Hoshi K; Uematsu M; Watanabe H; Migita K
    Tohoku J Exp Med; 2021 Feb; 253(2):151-157. PubMed ID: 33658450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in a small child: A case report.
    Mărginean MO; Molnar E; Chinceşan MI
    Medicine (Baltimore); 2020 Jan; 99(3):e18759. PubMed ID: 32011461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide combined with ruxolitinib for refractory hemophagocytic lymphohistiocytosis during pregnancy: a case report and literature review.
    Wang S; Wu J; Jing X; Zhang Y; Tang H; Wu J
    Hematology; 2019 Dec; 24(1):751-756. PubMed ID: 33138732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ruxolitinib in conjunction with the HLH-94 protocol for Epstein-Barr virus-related hemophagocytic lymphohistiocytosis in the intensive care unit: A case report.
    Huang Z; Xie J
    Medicine (Baltimore); 2021 Mar; 100(11):e25188. PubMed ID: 33726009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous panniculitis-like T-cell lymphoma presenting with hemophagocytic lymphohistiocytosis and skin lesions with characteristic high-resolution ultrasonographic findings.
    Hung GD; Chen YH; Chen DY; Lan JL
    Clin Rheumatol; 2007 May; 26(5):775-8. PubMed ID: 16465478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated hyperkeratotic and granulomatous nodules in a child with fatal Epstein-Barr-virus-associated hemophagocytic lymphohistiocytosis.
    Brinkmeier T; Reuter T; Metze D; Frosch PJ; Herbst RA
    Pediatr Dermatol; 2006; 23(1):35-8. PubMed ID: 16445409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic and Nodular Hyperinflammation in a Patient with Refractory Familial Hemophagocytic Lymphohistiocytosis 2.
    Segal JE; Daley JD; Barnum JL; Salgado CM; Reyes-Mugica M; Schneider C; Gumus S; Thakrar D; Allen SW; Canna SW
    J Clin Immunol; 2021 Jul; 41(5):987-991. PubMed ID: 33570715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis during pregnancy].
    Ikeda M; Oba R; Yoshiki Y; Shingaki S; Takei T; Miyazaki K; Abe Y; Tsukada N; Ishida T; Suzuki K
    Rinsho Ketsueki; 2017; 58(3):216-221. PubMed ID: 28381688
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.